-+ 0.00%
-+ 0.00%
-+ 0.00%

*AEON Biopharma: Cash and Cash Equivalents Expected to Fund Ops Into 3Q of 2026 >AEON

Dow Jones·05/14/2026 20:22:00

Please log in to view news